FIG. 4.
Concentrations of nelfinavir, M1, and M8 in plasma following administration of a single oral dose (day 1) and multiple oral doses (day 28) of nelfinavir mesylate (750 mg TID) to 10 HIV-positive patients. Data are means ± standard deviations.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.